In this current work, demonstrating the STAT6-mediated, long-term GVT effect, we investigated whether the same STAT6-dependent pathways promote the expression of proteins associated with anti-tumor immunity, where the mechanistic details of the potent GVT effect by STAT6VT transgenic T cells came from RNAseq experiments and data analysis based on previous observations using chromosome immune precipitation [23]. This evidence concerns the gene STAT6 and neoplasm.